Fempro

Fempro by Cipla is a pharmaceutical-grade, ultra-potent Aromatase Inhibitor (AI) featuring pure Letrozole at a concentration of 2.5mg per tablet. Manufactured under strict global quality standards by Cipla—one of the world’s leading pharmaceutical manufacturers—Fempro offers complete chemical consistency, high bioavailability, and exact dosing accuracy.

Letrozole is a non-steroidal type-II aromatase inhibitor and is widely considered the most powerful AI available. Developed primarily for oncology, Fempro is used in performance and athletic contexts to treat severe estrogenic side effects, eliminate intense fluid retention, and halt acute, rapidly presenting cases of estrogen-induced gynecomastia caused by heavy aromatizing compound cycles.

Key Benefits & Applications

• Maximum Systemic Estrogen Suppression: Capable of suppressing total circulating estradiol levels by up to 98%, making it unmatched in raw estrogen-lowering potency.

• Acute Gynecomastia Emergency Treatment: Acts as the premier “emergency response” compound to halt, shrink, and reverse rapidly developing glandular gynecomastia tissue on active cycles.

• Complete Subcutaneous Drying: Eliminates extreme subcutaneous water bloat and sodium retention, leaving a dry, hard, and deeply striated physical look.

• Blood Pressure Management: By removing heavy estrogenic fluid retention, Fempro helps alleviate blood pressure spikes associated with high aromatase levels.

• Potent HPTA Stimulation: Strongly blocks central estrogenic negative feedback at the hypothalamus, triggering a powerful increase in pituitary LH and FSH release.